IDEXX Laboratories, Inc. (IX1)
FSX
478.20
+3.60 (+0.76%)
Closed
Aug 25, 2026
Day's Range
478.20478.20
52 wk Range
450.10665.80
Financial Statements - IX1 - IDEXX Laboratories, Inc.
Revenue
4.30B▲ 30.3%
Net Income
1.05B▲ 40.9%Net Margin 24.6%
EBITDA
1.50B▲ 40.1%
Free Cash Flow
1.04B▲ 54.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.30B | 3.30B | 3.66B | 3.36B | 3.21B | 2.70B |
| Cost of Goods | 1.64B | 1.28B | 1.47B | 1.36B | 1.32B | 1.13B |
| Gross Profit | 2.65B | 2.01B | 2.18B | 2B | 1.88B | 1.57B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.36B | 955.90M | 1.09B | 898.76M | 932.02M | 694.52M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 1.32B | 940.22M | 1.06B | 859.97M | 902.65M | 661.98M |
| Income Tax | 264.72M | 188.04M | 216.13M | 180.88M | 157.81M | 79.85M |
| Net Income | 1.05B | 752.18M | 845.04M | 679.08M | 744.84M | 582.13M |
| EPS Basic | 13.17 | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 |
| EPS Diluted | 13.08 | 10.67 | 10.06 | 8.03 | 8.6 | 6.71 |
| Basic Shares Outstanding | 80.42M | 69.86M | 86.89M | 85.86M | 87.48M | 87.62M |
| Diluted Shares Outstanding | 80.42M | 69.86M | 86.89M | 85.86M | 87.48M | 87.62M |
| Ebit | 1.36B | 966.66M | 1.10B | 899.83M | 932.46M | 695.11M |
| Ebitda | 1.50B | 1.07B | 1.21B | 1.01B | 1.03B | 791.10M |
| Net Income Continuous Operations | 1.05B | 752.18M | 845.04M | 679.08M | 744.84M | 582.13M |
| Minority Interests | - | - | 0 | 0 | 1K | -355K |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
